IRIS Institutional Research Information System - OPENBS Open Archive UniBS

ALTOMARE, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.966
AS - Asia 1.496
EU - Europa 722
SA - Sud America 456
Continente sconosciuto - Info sul continente non disponibili 56
AF - Africa 46
OC - Oceania 4
Totale 4.746
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.854
SG - Singapore 614
BR - Brasile 368
CN - Cina 316
IT - Italia 190
VN - Vietnam 153
HK - Hong Kong 150
DE - Germania 135
BD - Bangladesh 82
GB - Regno Unito 75
RU - Federazione Russa 68
FR - Francia 65
CA - Canada 59
TR - Turchia 55
CZ - Repubblica Ceca 33
IN - India 33
AR - Argentina 28
AT - Austria 27
UA - Ucraina 27
FI - Finlandia 23
MX - Messico 20
EC - Ecuador 19
NL - Olanda 18
JP - Giappone 16
ZA - Sudafrica 14
ID - Indonesia 13
PL - Polonia 13
SE - Svezia 13
CO - Colombia 10
IQ - Iraq 9
VE - Venezuela 9
PY - Paraguay 8
CL - Cile 7
ES - Italia 7
JM - Giamaica 7
KE - Kenya 7
PK - Pakistan 7
BE - Belgio 6
CR - Costa Rica 6
HN - Honduras 6
MA - Marocco 6
UZ - Uzbekistan 6
JO - Giordania 5
PE - Perù 5
SA - Arabia Saudita 5
SV - El Salvador 5
PA - Panama 4
TW - Taiwan 4
AZ - Azerbaigian 3
DZ - Algeria 3
HU - Ungheria 3
IL - Israele 3
NP - Nepal 3
PT - Portogallo 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
AU - Australia 2
EG - Egitto 2
ET - Etiopia 2
IE - Irlanda 2
KZ - Kazakistan 2
LB - Libano 2
LT - Lituania 2
MY - Malesia 2
NO - Norvegia 2
PR - Porto Rico 2
PS - Palestinian Territory 2
QA - Qatar 2
RO - Romania 2
SC - Seychelles 2
SN - Senegal 2
TH - Thailandia 2
AM - Armenia 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DK - Danimarca 1
GA - Gabon 1
GD - Grenada 1
GM - Gambi 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
KG - Kirghizistan 1
KH - Cambogia 1
KI - Kiribati 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
UY - Uruguay 1
Totale 4.690
Salva come PNG Salva come JPEG
Città #
Singapore 299
San Jose 195
Ashburn 193
Hong Kong 150
Council Bluffs 133
The Dalles 119
Beijing 66
Los Angeles 62
New York 59
Ho Chi Minh City 53
Dallas 51
Lauterbourg 49
Santa Clara 48
Columbus 47
Istanbul 47
Munich 40
Hanoi 38
Boardman 35
Des Moines 32
Fairfield 32
Nuremberg 32
Buffalo 29
Chicago 28
Moscow 28
São Paulo 28
Houston 26
Romola 24
North Bergen 23
San Francisco 22
Milan 21
Woodbridge 21
Redondo Beach 19
Olomouc 17
Shanghai 17
Atlanta 16
Denver 16
Montreal 16
Orem 16
Turku 16
Brno 15
Seattle 15
Mumbai 14
Rio de Janeiro 14
Tokyo 14
Vienna 14
Brooklyn 13
London 13
Manchester 13
Frankfurt am Main 12
Phoenix 12
Stockholm 12
Toronto 12
Boston 11
Charlotte 11
Warsaw 11
Jacksonville 10
Wilmington 10
Curitiba 9
Naples 9
Rome 9
Turin 9
Belo Horizonte 8
Cambridge 8
Mexico City 8
Poplar 8
Ribeirão Preto 8
Amsterdam 7
Chandler 7
Düsseldorf 7
Helsinki 7
Nairobi 7
Philadelphia 7
Porto Alegre 7
Princeton 7
Chennai 6
Guayaquil 6
Hải Dương 6
Ottawa 6
Taranto 6
Tashkent 6
Amman 5
Brasília 5
Brussels 5
Buenos Aires 5
Cape Town 5
Dearborn 5
Florence 5
Goiânia 5
Jinan 5
Johannesburg 5
Kingston 5
Kunming 5
New Delhi 5
Padova 5
Quito 5
San José 5
San Salvador 5
São José dos Campos 5
Bari 4
Biên Hòa 4
Totale 2.655
Salva come PNG Salva come JPEG
Nome #
Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation 242
Do Beliefs about the Pathogenetic Role of Amyloid Affect the Interpretation of Amyloid PET in the Clinic. 212
Neuropsychiatric Symptoms in Frontotemporal Dementia: More Than Just Noise? 124
Multidomain interventions: state-of-the-art and future directions for protocols to implement precision dementia risk reduction. A user manual for Brain Health Services—part 4 of 6 110
Diagnostic value of amyloid-PET and tau-PET: a head-to-head comparison 105
Applying the ATN scheme in a memory clinic population: The ABIDE project 105
Clinical utility of FDG-PET for the clinical diagnosis in MCI 104
AMYPAD Diagnostic and Patient Management Study: Rationale and design 103
Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients: The AMYPAD-DPMS Randomized Clinical Trial 103
Accuracy and reproducibility of automated white matter hyperintensities segmentation with lesion segmentation tool: A European multi-site 3T study 102
Description of a European memory clinic cohort undergoing amyloid-PET: The AMYPAD Diagnostic and Patient Management Study 102
Plasma biomarkers for Alzheimer's disease: A field-test in a memory clinic 101
European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18 F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus 99
Harmonizing neuropsychological assessment for mild neurocognitive disorders in Europe 99
Comparison of visual criteria for amyloid-pet reading: Could criteria merging reduce inter-rater variability? 99
Medial temporal lobe atrophy and posterior atrophy scales normative values 99
Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia 99
Brain atrophy in Alzheimer's Disease and aging 98
Dementia prevention in memory clinics: recommendations from the European task force for brain health services 96
Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders 94
Brain Health Services: organization, structure, and challenges for implementation. A user manual for Brain Health Services—part 1 of 6 94
The probabilistic model of Alzheimer disease: the amyloid hypothesis revised 89
Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services—part 2 of 6 89
Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia 86
Protocols for cognitive enhancement. A user manual for Brain Health Services—part 5 of 6 86
Brain connectivity and metacognition in persons with subjective cognitive decline (COSCODE): rationale and study design 85
Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer’s disease 85
Time to Diagnosis and Its Predictors in Syndromes Associated With Frontotemporal Lobar Degeneration 85
Clinical applicability of quantitative atrophy measures on MRI in patients suspected of Alzheimer’s disease 84
Analysis of Psychological Symptoms Following Disclosure of Amyloid-Positron Emission Tomography Imaging Results to Adults with Subjective Cognitive Decline 84
Dementia risk communication. A user manual for Brain Health Services—part 3 of 6 84
Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia 83
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum 83
Outcomes of clinical utility in amyloid-PET studies: state of art and future perspectives 83
Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia 82
Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington’s disease 79
Home-based transcranial alternating current stimulation (tACS) in Alzheimer’s disease: rationale and study design 78
The amyloid imaging for the prevention of Alzheimer's disease consortium: A European collaboration with global impact 77
Quantitative appraisal of the Amyloid Imaging Taskforce appropriate use criteria for amyloid-PET 75
Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study 74
Prognostic value of Alzheimer’s biomarkers in mild cognitive impairment: the effect of age at onset 74
Comment: Is a Large-Scale Screening for Alzheimer's Disease Possible? Yes, in a Few Years 72
Precision prevention of Alzheimer's and other dementias: Anticipating future needs in the control of risk factors and implementation of disease-modifying therapies 70
Home-Based Gamma Transcranial Alternating Current Stimulation in Patients With Alzheimer Disease: A Randomized Clinical Trial 67
Societal and equity challenges for Brain Health Services. A user manual for Brain Health Services—part 6 of 6 66
A minimally invasive dried blood spot biomarker test for the detection of Alzheimer’s disease pathology 64
Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer’s disease 64
Multitracer model for staging cortical amyloid deposition using PET imaging 64
Quantification of [18F]florbetaben amyloid-PET imaging in a mixed memory clinic population: The ABIDE project 56
Feasibility of a standard cognitive assessment in European academic memory clinics 53
Recruitment of pre-dementia participants: main enrollment barriers in a longitudinal amyloid-PET study 53
The Clinical Use of Alzheimer's Disease Biomarkers in Patients with Mild Cognitive Impairment: A European Alzheimer's Disease Consortium Survey 48
The detection of GRN mutation carriers by progranulin blood protein levels from finger-stick collection 34
Totale 4.746
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.401
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.401
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202220 0 0 0 2 0 0 1 2 5 2 2 6
2022/202316 3 1 0 3 1 5 0 0 3 0 0 0
2023/2024214 3 2 7 0 0 11 2 1 5 55 16 112
2024/20251.152 31 1 57 148 76 79 137 17 189 84 195 138
2025/20262.498 221 367 201 362 234 149 326 68 147 190 141 92
2026/2027638 113 87 136 302 0 0 0 0 0 0 0 0
Totale 4.746